These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12092005)

  • 1. Recombinant human endostatin is beneficial to endothelial cell growth exposed to mildly oxidized low-density lipoproteins.
    Ren B; Wang Y; Rabasseda X; Wang YZ
    Methods Find Exp Clin Pharmacol; 2002 May; 24(4):195-9. PubMed ID: 12092005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation.
    Koba S; Pakala R; Watanabe T; Katagiri T; Benedict CR
    Prostaglandins Leukot Essent Fatty Acids; 2000 Dec; 63(6):329-35. PubMed ID: 11133169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation.
    Watanabe T; Pakala R; Katagiri T; Benedict CR
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):449-59. PubMed ID: 11862125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor interaction of short-course endostatin and ionizing radiation.
    Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
    Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes.
    Ergün S; Kilic N; Wurmbach JH; Ebrahimnejad A; Fernando M; Sevinc S; Kilic E; Chalajour F; Fiedler W; Lauke H; Lamszus K; Hammerer P; Weil J; Herbst H; Folkman J
    Angiogenesis; 2001; 4(3):193-206. PubMed ID: 11911017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma.
    Ye C; Feng C; Wang S; Liu X; Lin Y; Li M
    Endocrinology; 2002 Sep; 143(9):3522-8. PubMed ID: 12193566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
    Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
    Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
    Yokoyama Y; Dhanabal M; Griffioen AW; Sukhatme VP; Ramakrishnan S
    Cancer Res; 2000 Apr; 60(8):2190-6. PubMed ID: 10786683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide.
    Watanabe T; Takahashi K; Kanome T; Hongo S; Miyazaki A; Koba S; Katagiri T; Pakara R; Benedict CR
    Hypertens Res; 2006 Oct; 29(10):821-31. PubMed ID: 17283870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy.
    Joki T; Machluf M; Atala A; Zhu J; Seyfried NT; Dunn IF; Abe T; Carroll RS; Black PM
    Nat Biotechnol; 2001 Jan; 19(1):35-9. PubMed ID: 11135549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of human endothelial cell growth by mildly oxidized low density lipoprotein.
    Maier JA; Barenghi L; Bradamante S; Pagani F
    Atherosclerosis; 1996 Jun; 123(1-2):115-21. PubMed ID: 8782842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endostatin inhibits adhesion of endothelial cells to collagen I via alpha(2)beta(1) integrin, a possible cause of prevention of chondrosarcoma growth.
    Furumatsu T; Yamaguchi N; Nishida K; Kawai A; Kunisada T; Namba M; Inoue H; Ninomiya Y
    J Biochem; 2002 Apr; 131(4):619-26. PubMed ID: 11927001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
    Beck MT; Chen NY; Franek KJ; Chen WY
    Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
    Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR
    Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells.
    Jougasaki M; Kugiyama K; Saito Y; Nakao K; Imura H; Yasue H
    Circ Res; 1992 Sep; 71(3):614-9. PubMed ID: 1499109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascorbic acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein formation.
    Hwang J; Peterson H; Hodis HN; Choi B; Sevanian A
    Atherosclerosis; 2000 Jun; 150(2):275-84. PubMed ID: 10856519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma.
    Dhanabal M; Ramchandran R; Volk R; Stillman IE; Lombardo M; Iruela-Arispe ML; Simons M; Sukhatme VP
    Cancer Res; 1999 Jan; 59(1):189-97. PubMed ID: 9892206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allicin prevents oxidized low-density lipoprotein-induced endothelial cell injury by inhibiting apoptosis and oxidative stress pathway.
    Chen X; Pang S; Lin J; Xia J; Wang Y
    BMC Complement Altern Med; 2016 May; 16():133. PubMed ID: 27207282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor.
    Kuzuya M; Ramos MA; Kanda S; Koike T; Asai T; Maeda K; Shitara K; Shibuya M; Iguchi A
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):765-70. PubMed ID: 11348872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.